COVID-19: Bahrain approves emergency use for regn-cov2 medicine

Report says updating treatment protocol would reduce symptoms, complications

Last updated: June 16, 2021 | 22:51

Reuters

1 MIN READ

Manama city, Bahrain

Shutterstock

Also In This Package

Photos: Biden, Putin handshake kicks off Geneva summit

Troubled zoo starts 'Sponsor an Animal' to raise money

World's top billionaires who give their wealth away

Photos: 30 turtles released back into Dubai waters

Readers' photos: Deserts in the UAE

Pakistani stars get down to business

Cairo: Bahrain on Wednesday approved the emergency use for regn-cov2 medicine, Regeneron Pharmaceuticals Incs and Roche's newly authorised COVID-19 antibody combination, as part of its coronavirus treatment protocol to treat existing cases with mild and moderate symptoms, the state news agency (BNA) reported.

The report said updating the corona treatment protocol in the kingdom would reduce symptoms complications.

Get the latest news and updates straight to your inbox